Navigation Links
AEterna Zentaris to Present at Upcoming CIBC World Markets 7th Annual Eastern Investor Conference
Date:9/17/2008

QUEBEC CITY, Sept. 17 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS, TSX: AEZ), a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that its Senior Vice President and Chief Financial Officer, Dennis Turpin, CA, will present a company overview at the upcoming CIBC World Markets 7th Annual Eastern Investor Conference on Tuesday, September 23, 2008 at 3:25 pm (eastern time), at the Centre Sheraton Hotel in Montreal, Canada.

A live webcast of the presentation will be available on AEterna Zentaris' website at http://www.aezsinc.com in the Investors section. A replay will also be available for a period of 30 days on the Company's website.

About AEterna Zentaris Inc.

AEterna Zentaris Inc. is global biopharmaceutical company focused on endocrine therapy and oncology with proven expertise in drug discovery, development and commercialization. News releases and additional information are available at http://www.aezsinc.com.


'/>"/>
SOURCE AETERNA ZENTARIS INC.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. AEterna Zentaris Reports Second Quarter 2008 Financial and Operating Results
2. AEterna Zentaris Announces Appointment of Prof. Jurgen Engel, Ph.D. as New President and CEO
3. AEterna Zentaris to Announce Second Quarter 2008 Financial and Operating Results on August 12, 2008
4. AEterna Zentaris Sells Quebec City Building for $7.1 million
5. AEterna Zentaris to Present at Upcoming Rodman & Renshaw Global Healthcare Conference and AUA Annual Meeting
6. AEterna Zentaris: Article on Phase 2 Trial with Cetrorelix in BPH to be Published in European Urology Journal
7. AEterna Zentaris Reports First Quarter 2008 Financial and Operating Results
8. AEterna Zentaris to Announce First Quarter 2008 Financial and Operating Results and Hold Annual Shareholder Meeting on May 7, 2008
9. AEterna Zentaris: Lead Investigator for Cetrorelix Trials in BPH Wins Best Poster Presentation Award at European Association of Urology Meeting in Milan
10. AEterna Zentaris Partner, Spectrum, Provides Update on Ozarelix in Benign Prostatic Hyperplasia
11. AEterna Zentaris Completes Patient Recruitment for First Phase 3 Efficacy Trial with Cetrorelix in Benign Prostatic Hyperplasia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2016)... ... May 18, 2016 , ... ... Summer Camp at The University of Toledo. This two-day camp will take place ... to explore the field of pharmaceutical sciences in preparation for a university academic ...
(Date:5/18/2016)... ... May 18, 2016 , ... ... a direct result of asthma complications.* Costing more than $56 billion in direct ... , “For too many, the suffering associated with uncontrolled asthma can ...
(Date:5/17/2016)... ZURICH, Switzerland , May 18, 2016 ... their GONAL-f® 2.0 prefilled pen following approval by EMA, ... Merck, a leading science and technology company, the new ... and bring an increased level of confidence to patients ... the new GONAL-f® prefilled pen easier to handle with ...
(Date:5/17/2016)... ... May 17, 2016 , ... PATH and Laerdal Global Health ... bring a feeding cup to market based on a reference design co-developed by ... Seattle Children’s Hospital, thereby ensuring an innovative feeding option for the 7.6 million ...
Breaking Biology Technology:
(Date:4/19/2016)... 2016 The new GEZE SecuLogic ... web-based "all-in-one" system solution for all door components. It ... the door interface with integration authorization management system, and ... The minimal dimensions of the access control and the ... installations offer considerable freedom of design with regard to ...
(Date:3/31/2016)... BOCA RATON, Florida , March 31, 2016 /PRNewswire/ ... LEGX ) ("LegacyXChange" or the "Company") ... presentation for potential users of its soon to be ... The video ( https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also ... by the use of DNA technology to an industry ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):